1. Al-Maaieh A, Aburub A (2005) Salt effect on a neutral species reaction: acidic hydrolysis of aspirin. AAPS J 7(S2)
2. Buellesbach R (2007) Aspirin®: a sucessful example of formulation technology. In: Bröckel U, Meier W, Wagner G (eds) Product design and engineering: best practices. Wiley-VCH, Weinheim, pp 569–582
3. Doyle G, Jayawardena S, Ashraf E, Cooper SA (2002) Efficacy and tolerability of non-prescription ibuprofen versus celecoxib for dental pain. J Clin Pharmacol 42:912–919
4. European Medicines Agency (2010) Committee for Medicinal Products for Human Use (CHMP). Guideline on the Investigation of Bioequivalence. CPMP/QWP/EWP/1401/98 Rev. 1, London, 20 January 2010
5. Fahmy R, Marnane W, Bensley D, Hollenbeck RG (2001) Dissolution testing of veterinary products. Dissolution testing of aspirin boluses. Dissolution Technol 8(1):8–14